Approach

Market Conditions, Stock Selection, Risk Management and Disciplined Investing

Once you choose a system, you need to stick with it ... Warren Buffett, Legendary Investor

Our Approach is simple and straightforward. We invest in stocks, which demonstrate growing valuation, within a strict risk management framework. Success feeds on itself. Potential earnings growth drives valuations. Earnings in turn are affected by various systemic factors like economic cycle and the interest rate environment, and unsystemic, company-specific, factors like new markets, product cycles, management changes, etc. We strive to achieve returns superior to benchmarks, while realizing that we have to accept what the market is willing to give. The four constructs of our investment approach are Market Conditions, Stock Selection, Risk Management, and Disciplined Investing - all aiming to generate, enhance and preserve Returns and building investment wealth consistently over the long term.

  • Market Conditions

    Market Conditions are uncertain and that is why investing is a very careful and deliberate exercise.  Market is our ultimate guide. We approach investing when conditions are most favorable. Even great stocks are adversely affected in an adverse market. Our models provide directional guidance for the broader market. This assists us to manage the resistance from headwind, and race with a tailwind. In the end, we don’t force our way but accept what the market is willing to offer. Consequently, we manage our investment exposure based on market conditions, and can be fully invested, partly invested or uninvested.

  • Stock Selection

    Based on the investing focus of the portfolio – industry specific, Small Cap, Large Cap, ETFs – our quantitative-driven stock selection models evaluate companies on various parameters. The process narrows down the pool of attractive candidates and eventually a ranked list of stocks is generated that represent promising investments within the parameters. Additional criteria is used to select the model portfolio comprising stocks showing favorable market action. The model portfolio stocks are equal-weighted at the time of investment. If a position rises, we do not trim it but let it grow. Consequently, over time some positions may have a higher portfolio weight as they grow more than other positions, even though a similar amount was invested. The models are revised at our discretion.

  • Risk Management

    Risk Management is critically important.

    Nonetheless, no system can identify all kinds of risk with complete certainty.  We recognize that, and have built a layered risk management approach to improve our risk management function.

    Our various Risk Management layers include a series of market indicators that determine our entry or exit in the broader market. Even stocks with good earnings momentum get bogged down in adverse broader stock market conditions. So we are fully invested in the market when our indicators recommend, while scaling back based on rising market uncertainty, when our focus becomes Return Preservation – not losing what we have earned. Scaling back is relatively easier for individual investors over institutional investors, and it’s an advantage investors should leverage.

    Additionally, we use portfolio diversification in our approach to limit company-specific or unsystematic risk, as well as in the case of non-sector products we have multiple sectors and industries represented in the portfolio.

    Thereafter, we limit the amount we invest in any single stock. Depending on the investment product you subscribe to, such a position limit can be typically in the range of 8%-12.5% range.

    As a final risk management defense, we close out a position at the end of the month if it loses its ranking as determined by the models. Sometimes these positions can be running a material loss at the time we close them out. We don’t dwell on it and simply replace the stock with one that the quantitative models determine to be promising.

    Even all of the above doesn’t guarantee that there will be no blow-ups. That is unavoidable in any stock portfolio. We have had such instances in the past and they will occur again. Recognizing that we cannot avoid loses in some individual stocks, we pursue a methodology of managing the losses, when such situations occur, and focusing on the total portfolio return. As an investor, one must shift risk management towards a portfolio approach from an individual stock approach. Our model portfolios have managed such drawdowns, and still outperformed the market indexes significantly. The objective of our Risk Management approach is to diminish the probability of losses and blow-ups, while equipping our portfolio to manage the losses when they do occur.

    In some products, we may consider using stop-loss triggers to liquidate our positions. But in products like the Prudent Biotech Portfolio and the Smallcap Portfolio, where the typical price variance is higher than the broader market, we presently do not adopt stop-loss triggers due to the likelihood of false positives or being sold out in the normal volatility of the sector.

    Also, it is important to note that our systematic investment strategies are developed with the objective of maximizing returns. Consequently, the model portfolios will be much more volatile than the broader market as represented by the S&P 500 and other indexes. Also, we only reset the model portfolio at the beginning of each month, and consequently there can be times when the market conditions change faster than our response. In addition, sector-focused products like the Prudent Biotech Portfolio cannot benefit from diversification across industries, and consequently will be more volatile.

    Finally, please note that momentum investing strategies are very volatile and not for everyone. One has to understand that there will be sharp changes and it can be painful. But with discipline and time, quality momentum strategies based on models can avoid the behavioral biases and significantly outperform the broader market.

    Our performance captures these ups-and-downs.

  • Disciplined Investing

    Wealth Building requires discipline and patience.

    Any pursuit requires the rigor of discipline. This is true in investing as well.

    In fact, discipline is a foundation bedrock of Systematic Investing. The best methodologies and plans fail for lack of execution discipline. In times of stress, the system that is designed to manage portfolio losses and preserve gains is compromised by investor inability to execute as per system recommendations. It’s natural to be sucked into the vortex of emotions – fear, greed, regret, pain – during times of market turmoil. We have to manage our behavioral tendencies and not deviate from our plan.

    Paraphrasing legendary quantitative hedge fund manager Jim Simons, we follow our system slavishly and it has turned out to be a pretty good business.

    Discipline is such an important ingredient to the success of our model and investing in general, that we discuss it in greater detail in our section on Systematic Investing, which lays down the case for the merits of pursuing a model-driven investing strategy.

Why Systematic Investing

Graycell Advisors, and its affiliates, officers, employees, families, and all other related parties, collectively referred to as ‘Graycell’ and/or ‘we,’ is a publisher of financial information, such as the Smallcap, and Prudent Biotech newsletters. We are not a Registered Investment Advisor (RIA). Historical performance figures provided are hypothetical and unaudited, and based on our proprietary analysis and system performance, back-tested over an extended period of time. Hypothetical or simulated performance results have limitations, and unlike an actual performance record, simulated results do not represent actual trading and consequently do not involve financial risk of actual trading. The performance results obtained are intended for illustrative purposes only. No representation is being made that an account will or is likely to achieve profit or losses similar to those shown. Past performance is not indicative of future results, which may vary. All stock and related investments have a degree of risk, which can result in a significant or total loss. In addition, biotech sector and smallcaps are characterized by much higher risk and volatility than the general stock market. Information contained herein is general and does not constitute a personal recommendation or takes into account the particular investment objectives, financial situations, or needs of individual investors. If you decide to invest in any of the stocks of the companies mentioned in the newsletters, samples, alerts, etc., sent to you or available on our websites, you can and may lose some or all of your investment. You alone are responsible for your investment decisions. Use of the information herein is at one's own risk. We are simply sharing the results of our model. Nothing should be construed as a recommendation or an offer to buy or sell any securities, and we are not liable nor do we assume any liability or responsibility for losses incurred as a result of any information provided or not provided or not made available in a timely manner, herein or on our website or using any other medium. We cannot guarantee the accuracy and completeness of any information furnished by us. We may or may not have existing positions in the stocks mentioned in our reports. Our models are proprietary and/or licensed, and can be changed or revised based on our discretion at any time without any notification. Subscribers and investors should always conduct their own due diligence with any potential investment, and consider obtaining professional advice before making an investment decision.
© Graycell Advisors. All rights reserved. Any act of copying, reproducing or distributing this newsletter whether wholly or in part, for any purpose without the written permission of Graycell Advisors is strictly prohibited and shall be deemed to be copyright infringement.